Basics of Regulatory Due Diligence for Product Development

Regulatory due diligence is a crucial aspect of product development in the pharmaceutical, biotechnology, and medical device industries. It ensures that products meet regulatory standards and are compliant with laws before reaching the market. Below is an instructive guide on the basics of regulatory due diligence, focusing on its importance, process, and key elements.

Regulatory Compliance & Due Diligence : At Masuu, our technical team and scientific advisory board offer expert guidance for ensuring facility and dossier compliance according to specific health authority requirements and guidelines. During national and international facility mergers and acquisitions, we provide both regulatory dossiers and comprehensive facility assessments to our clients.

  1. Understand Regulatory Requirements
The first step in regulatory due diligence is gaining a clear understanding of the regulatory requirements in the target market. Different regions, such as the US, Europe, and Japan, have distinct regulations and approval processes. These include product classifications, clinical trial requirements, labeling standards, and post-market surveillance. Familiarize yourself with the regulatory agencies, such as the FDA in the US, EMA in Europe, and MHLW in Japan, and their specific guidelines.

  1. Evaluate Product Classification
Regulatory agencies classify products based on their intended use, risk level, and product type. A product’s classification dictates the regulatory pathway for approval. For instance, drugs and biologics may require clinical trials and pre-market approval, while certain medical devices might only need a registration process. Understanding the correct classification helps determine the necessary documentation and testing required for approval.

  1. Assess the Regulatory Pathway
After determining the product classification, the next step is to map out the regulatory pathway. This pathway varies depending on the product type. For pharmaceuticals, this may involve New Drug Applications (NDAs) or Abbreviated New Drug Applications (ANDAs). For medical devices, it could involve a 510(k) submission in the US or a CE mark in Europe. Research the timelines, fees, and documentation required for each type of submission.

  1. Review Clinical Data and Trials
Regulatory agencies require comprehensive clinical data to demonstrate a product’s safety and efficacy. If clinical trials are required, ensure that the design, methodology, and data collection are compliant with Good Clinical Practice (GCP). Thoroughly review any existing clinical data and trial reports to assess their compliance with regulatory standards. In some cases, foreign clinical data may be accepted, but you must ensure it aligns with the regulatory agency’s expectations.

  1. Examine Manufacturing and Quality Assurance
Regulatory agencies expect that products are manufactured in compliance with Good Manufacturing Practice (GMP) standards. Evaluate the manufacturing processes to ensure they meet the required quality standards, including any documentation such as batch records, testing results, and process validation. Ensure the manufacturing facility is properly licensed and follows the necessary quality assurance procedures.

  1. Prepare Documentation
Documentation plays a key role in the regulatory approval process. This includes product dossiers, labeling, clinical trial reports, manufacturing procedures, and safety data. Ensure all required documentation is prepared in the format prescribed by the regulatory agency. A thorough review of these documents is essential to prevent any discrepancies or delays during the approval process.

  1. Post-Market Surveillance
Regulatory due diligence doesn’t end with approval. Ongoing post-market surveillance is necessary to monitor the product’s performance in the market, track adverse events, and ensure compliance with safety regulations. Prepare a plan for monitoring the product after launch, including periodic reporting to regulatory authorities.

Regulatory due diligence is essential to the successful development and commercialization of products in regulated markets. By thoroughly understanding the regulatory requirements, evaluating product classifications, reviewing clinical data, and ensuring compliance with manufacturing standards, you can ensure a smooth regulatory approval process and mitigate potential risks. Preparing the necessary documentation and establishing a post-market surveillance plan will help maintain regulatory compliance long after the product reaches the market.

Masuu specializes in Pharma Regulatory Affairs Due Diligence services, which are tailored to meet the specific needs of the pharmaceutical and life sciences industries. Our Regulatory Affairs Subject Matter Experts (SMEs) conduct thorough assessments to evaluate current regulatory practices, identify potential gaps or risks, and offer strategic recommendations to enhance compliance and streamline regulatory processes

Frequently Asked Questions

Regulatory due diligence is the process of assessing whether a pharmaceutical, biotechnology, or medical device product meets applicable regulatory requirements before reaching the market. It involves reviewing regulatory requirements, product classification, clinical data, manufacturing practices, documentation, and post-market obligations to identify potential compliance gaps and regulatory risks.

Regulatory due diligence helps companies understand applicable requirements before advancing a product toward commercialization. It includes evaluating regulatory pathways, clinical evidence, manufacturing practices, documentation, and post-market obligations. This assessment can identify potential gaps or risks early and support compliance with the requirements of the intended regulatory market.

Regulatory due diligence should consider requirements applicable to the target market, including product classification, clinical trial requirements, labeling standards, approval processes, and post-market surveillance. The specific requirements vary between regions and regulatory authorities, so companies need to assess the rules and guidelines applicable to their intended market.

Product classification determines the regulatory pathway that may apply to a product. Classification can depend on factors such as intended use, product type, and risk level. The resulting classification influences the documentation, testing, clinical evidence, and approval requirements that need to be considered during regulatory due diligence.

Regulatory pathway assessment involves determining the appropriate route for obtaining product approval based on its classification and intended market. The page identifies examples including NDAs and ANDAs for pharmaceuticals, and 510(k) submissions in the United States or CE marking in Europe for medical devices, along with associated requirements.

Clinical data and trial reports are reviewed to assess whether they meet applicable regulatory expectations for safety and efficacy evidence. Where clinical trials are required, their design, methodology, and data collection should comply with Good Clinical Practice. Existing foreign clinical data may also require assessment against the relevant authority’s expectations.

Manufacturing assessments examine whether production processes comply with applicable Good Manufacturing Practice standards. The review can include batch records, testing results, process validation, facility licensing, and quality-assurance procedures. These checks help determine whether the manufacturing operation and supporting documentation meet the quality requirements expected by the relevant regulatory authority.

Documentation reviewed during regulatory due diligence can include product dossiers, labeling, clinical trial reports, manufacturing procedures, and safety data. The page emphasizes preparing documentation in the format prescribed by the relevant regulatory agency and conducting a thorough review to identify discrepancies that could affect the approval process.

Yes. Regulatory due diligence and compliance considerations continue after approval through post-market surveillance. Companies need to monitor product performance, track adverse events, and maintain compliance with applicable safety requirements. The page also highlights the importance of establishing a post-market monitoring plan and making periodic reports to regulatory authorities.

A regulatory due diligence assessment can identify current regulatory practices, potential compliance gaps, and regulatory risks. Masuu Global states that its Regulatory Affairs subject matter experts conduct assessments tailored to pharmaceutical and life-sciences organizations and provide strategic recommendations intended to strengthen compliance and streamline regulatory processes.

Book a Demo